Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human DNA polymerases are a group of essential enzymes responsible for the synthesis and repair of DNA in both the nucleus and mitochondria. The nuclear polymerases, including families A, B, X, and Y, perform distinct roles such as bulk genomic replication (Pol alpha, delta, epsilon) and specialized DNA repair (Pol beta, lambda, mu) [StatPearls, 2023]. The mitochondrial DNA polymerase, Pol gamma, is the sole enzyme responsible for the replication and maintenance of the mitochondrial genome [UniProt P54098]. These enzymes are critical therapeutic targets; for example, many nucleoside analog chemotherapies like Cytarabine and Gemcitabine target nuclear polymerases to inhibit cancer cell proliferation [PubMed, 2021]. However, they are also significant sites of off-target drug toxicity. Specifically, the inhibition of Pol gamma by certain antiviral nucleoside reverse transcriptase inhibitors (NRTIs) can lead to mitochondrial DNA depletion, resulting in severe clinical conditions such as lactic acidosis, myopathy, and lipodystrophy [NIH, 2022]. Furthermore, mutations in polymerase genes like POLE and POLD1 serve as important biomarkers for hypermutation status and immunotherapy sensitivity in various cancers [PubMed, 2019].
Inhibition of DNA synthesis through competitive binding with deoxyribonucleotide triphosphates (dNTPs) or by acting as chain terminators after incorporation into the nascent DNA strand [StatPearls, 2023].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human DNA polymerases (DNA Pol).